Testing serum batches for mouse embryonic stem cell culture

Richard Behringer, Marina Gertsenstein, Kristina Vintersten Nagy, Andras Nagy

Research output: Contribution to journalArticleOtherpeer-review

Abstract

The variability in embryonic stem (ES) cell culture is due primarily to serum. Serum is typically produced in large batches from many animals. However, samples may differ depending on the age and diet of the animals, the country of origin, and other factors creating lot-to-lot variations. Some vendors test FBS lots for compatibility with ES cell culture. Many laboratories prefer to test serum batches themselves to identify the lot giving optimal growth. In this protocol, small quantities of specific serum batches are obtained from different suppliers and tested for their ability to support ES cells in an undifferentiated state. A complete test includes the serum batches’ influence on plating efficiency, cell morphology, toxicity, and, if possible, their ability to support generation of chimeras.

Original languageEnglish
Pages (from-to)988-991
Number of pages4
JournalCold Spring Harbor Protocols
Volume2017
Issue number12
DOIs
Publication statusPublished - 1 Dec 2017

Cite this

Behringer, Richard ; Gertsenstein, Marina ; Nagy, Kristina Vintersten ; Nagy, Andras. / Testing serum batches for mouse embryonic stem cell culture. In: Cold Spring Harbor Protocols. 2017 ; Vol. 2017, No. 12. pp. 988-991.
@article{7b47c8ca33b44ab2b0ca8534a3efcaa7,
title = "Testing serum batches for mouse embryonic stem cell culture",
abstract = "The variability in embryonic stem (ES) cell culture is due primarily to serum. Serum is typically produced in large batches from many animals. However, samples may differ depending on the age and diet of the animals, the country of origin, and other factors creating lot-to-lot variations. Some vendors test FBS lots for compatibility with ES cell culture. Many laboratories prefer to test serum batches themselves to identify the lot giving optimal growth. In this protocol, small quantities of specific serum batches are obtained from different suppliers and tested for their ability to support ES cells in an undifferentiated state. A complete test includes the serum batches’ influence on plating efficiency, cell morphology, toxicity, and, if possible, their ability to support generation of chimeras.",
author = "Richard Behringer and Marina Gertsenstein and Nagy, {Kristina Vintersten} and Andras Nagy",
year = "2017",
month = "12",
day = "1",
doi = "10.1101/pdb.prot092411",
language = "English",
volume = "2017",
pages = "988--991",
journal = "Cold Spring Harbor Protocols",
issn = "1940-3402",
number = "12",

}

Testing serum batches for mouse embryonic stem cell culture. / Behringer, Richard; Gertsenstein, Marina; Nagy, Kristina Vintersten; Nagy, Andras.

In: Cold Spring Harbor Protocols, Vol. 2017, No. 12, 01.12.2017, p. 988-991.

Research output: Contribution to journalArticleOtherpeer-review

TY - JOUR

T1 - Testing serum batches for mouse embryonic stem cell culture

AU - Behringer, Richard

AU - Gertsenstein, Marina

AU - Nagy, Kristina Vintersten

AU - Nagy, Andras

PY - 2017/12/1

Y1 - 2017/12/1

N2 - The variability in embryonic stem (ES) cell culture is due primarily to serum. Serum is typically produced in large batches from many animals. However, samples may differ depending on the age and diet of the animals, the country of origin, and other factors creating lot-to-lot variations. Some vendors test FBS lots for compatibility with ES cell culture. Many laboratories prefer to test serum batches themselves to identify the lot giving optimal growth. In this protocol, small quantities of specific serum batches are obtained from different suppliers and tested for their ability to support ES cells in an undifferentiated state. A complete test includes the serum batches’ influence on plating efficiency, cell morphology, toxicity, and, if possible, their ability to support generation of chimeras.

AB - The variability in embryonic stem (ES) cell culture is due primarily to serum. Serum is typically produced in large batches from many animals. However, samples may differ depending on the age and diet of the animals, the country of origin, and other factors creating lot-to-lot variations. Some vendors test FBS lots for compatibility with ES cell culture. Many laboratories prefer to test serum batches themselves to identify the lot giving optimal growth. In this protocol, small quantities of specific serum batches are obtained from different suppliers and tested for their ability to support ES cells in an undifferentiated state. A complete test includes the serum batches’ influence on plating efficiency, cell morphology, toxicity, and, if possible, their ability to support generation of chimeras.

UR - http://www.scopus.com/inward/record.url?scp=85037028574&partnerID=8YFLogxK

U2 - 10.1101/pdb.prot092411

DO - 10.1101/pdb.prot092411

M3 - Article

VL - 2017

SP - 988

EP - 991

JO - Cold Spring Harbor Protocols

JF - Cold Spring Harbor Protocols

SN - 1940-3402

IS - 12

ER -